AGINKO Research is the premiere CRO for preclinical work in osteoarticular pathologies. We offer a wide range of contract research services to support Drug and Medical Device established companies as well as start-ups and academia. From industry standard protocols to customized research design, our animal models and assays, both on an in vivo or in vitro basis, provide key tools for compound discovery and product development.
Given our expertise, know-how, and network in the field of osteoarticular pathologies, AGINKO today also offers a full range of histology services for your preclinical and clinical trials as well as general consulting services (e.g., regulatory, strategy, financing) devoted to osteoarticular pathologies.
BioCentrum's mission is to create a platform for our clients and partners in order to help them translate innovative discoveries into preclinical candidates with improved chances to become marketed in the least amount of time possible. Our offer is a range of in vitro and in vivo assays that are created toward incorporating preclinical information into your pipeline.
Admescope is a contract research organisation (CRO) providing the pharmaceutical, biotechnology and veterinary industry with premium quality tailor-made services to drug discovery in the area of ADME-Tox.
The service offering is widely spread, from highly tailored and optimised studies to high-throughput screening. Admescope’s unique expertise lies in in vitro & in vivo drug metabolism; including metabolite profiling & identification, drug-drug interactions and quantitative bioanalysis. The right level of research can always be found for the customer whether in the discovery or lead optimisation phase.
All of the services include comprehensive study consulting which enables tailoring the study according to customers’ specific needs. The state-of-art quality data is ensured by optimising the conditions according to the compounds instead of using generic protocols. All of the data can be interpreted for the customer and helped to understand the real meaning of the numerical values and observations.
• in vitro Metabolism
• in vivo DMPK
• Drug Interactions
• Quantitative Bioanalysis
• Permeability & Transporters
• Physicochemistry & Binding
• in vitro Toxicology
APTYS is a CRDO (contract research and development organization) which develops innovative products based of its expertise in pharmaceutical technologies and peptide delivery.
APTYS offers ISO9001 aligned contract service, according to cGMP.
Custom-made formulation development including in vivo/in vitro assessments.
Semi solid dosage forms for topical and transdermal delivery.
Injectable peptide depot formulations.
Analytical development and validations.
Quality control and ICH stability.
We provide world-class analytical instruments and services for validating, selecting and optimizing drug candidates. For our track record of 75+ analyzed candidates we have so far improved the overall clinical trial success rate by more than 4x. By accurately classifying candidates prior to clinical trials, we allow pharmaceutical companies to focus on the most promising candidates, increasing their efficiency and profitability.
Attana was founded with the vision of in vitro characterization of molecular interactions, mimicking in vivo conditions. We have developed proprietary label free biosensors for biochemical, crude, sera, and cell-based assays. We are also developing the Attana Virus Analytics (AVA) platform, a proprietary in vitro diagnostics (IVD) tool, for e.g. SARS-CoV-2 testing and immunity profiling.
To learn more about our latest services and products, please visit www.attana.com or contact firstname.lastname@example.org.